Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-23-002371
Filing Date
2023-06-12
Accepted
2023-06-12 16:13:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 arrowmark-cccc053123a2.htm SC 13G/A 52551
  Complete submission text file 0001172661-23-002371.txt   54172
Mailing Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206
Business Address 100 FILLMORE STREET, SUITE 325 DENVER CO 80206 303.398.2929
ArrowMark Colorado Holdings LLC (Filed by) CIK: 0001483859 (see all company filings)

EIN.: 392068140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Subject) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91763 | Film No.: 231008209
SIC: 2836 Biological Products, (No Diagnostic Substances)